The NLCA Quality Improvement goals, developed in consultation with stakeholders in the Clinical Reference Group, are:
- Improve early diagnosis of lung cancer
- Increase the proportion of patients who receive treatment with curative intent
- Increase the proportion of people with lung cancer receiving Systemic Anti-Cancer Therapy (SACT) and reduce unwarranted variation in access to SACT
- Improve the quality of the patient pathway
- Improve and reduce variation in lung cancer outcomes